Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
Druker BJ; Talpaz M; Resta DJ; Peng B; Buchdunger E; Ford JM; Lydon NB; Kantarjian H; Capdeville R; Ohno-Jones S; Sawyers CL; The New England Journal Of Medicine, 2001, vol. 344, issue 14, p 1031, ISSN 00284793. ISBN 00284793.
Full Text Resources Located for this Citation